| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_bfa1e449687f7c81effa5a5978dc65a7
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_c99e26b2e99b986993bb43cf0be5564f
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_b649ded9a6b0637cd1f07f1abf1cd997
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_97f8939cf76e68731c5704c708ac7a89 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-28
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-284
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-2846
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-2886 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-00 |
| filingDate |
2005-05-18-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d59741bfea35a0f0d875a3fc8991f2b4
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_64a70dde84badee1b189aa99460686e5
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_eef618c77f76b51c7aec413720874d61 |
| publicationDate |
2006-02-02-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
WO-2006010394-A2 |
| titleOfInvention |
Medicament in a multilayer form |
| abstract |
The invention relates to a medicament in a multilayer form, containing a) a core with a pharmaceutical agent, b) an inner coating, 50 to 95 percent by weight of which are composed of a (co)polymer comprising 95 to 100 percent by weight of radically polymerized vinylic monomers with neutral side groups and 0 to 5 percent by weight of monomers with anionic side groups, c) an outer coating made of a copolymer comprising 75 to 95 percent by weight of radically polymerized C<SUB>1</SUB> to C<SUB>4</SUB> alkyl esters of acrylic acid or methacrylic acid and 5 to 25 percent by weight of (meth)acrylate monomers with an anionic group in the alkyl radical. Said medicament further contains 5 to 30 percent by weight of common pharmaceutical auxiliaries, particularly emollients. The inventive medicament is characterized in that the inner coating contains 5 to 50 percent by weight of common pharmaceutical auxiliaries which are no expanding agents while the amount of expanding agents provided is less than 5 percent by weight. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9241910-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2009154810-A2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9795576-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-107712706-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8920838-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9504699-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2012076834-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2009154810-A3 |
| priorityDate |
2004-07-23-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |